Respirable antisense oligonucleotide (RASON) therapy for allergic asthma

BioDrugs

Volumn 12, Issue 4, 1999, Pages 237-243

  Metzger, W James ^a   Nyce, Jonathan W ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EpiGenesis Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ANTIASTHMATIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETA1 INTEGRIN; CHEMOKINE RECEPTOR; EPI 2010; HISTAMINE; HOUSE DUST ALLERGEN; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5 RECEPTOR; MESSENGER RNA; PHOSPHOROTHIOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR DOWN REGULATION; REVIEW;

EID: 0032737130     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199912040-00001     Document Type: Review

References (37)

1. Nyce JW, Metzger WJ. DNA antisense therapy for asthma in an animal model. Nature 1997; 385: 721-25
2. Henry SP, Zuckerman JE, Rojko J, et al. Toxicological properties of several novel oligonucleotide analogs in mice. Anticancer Drug Des 1997 Jan; 12 (1): 1-14
3. Cohen AS, Bousquet AJ, Wang BH, et al. A nonradioisotope approach to study the in vivo metabolism of phosphorothioate oligonucleotides. Antisense Nucleic Acid Drug Dev 1997 Feb; 7 (1): 13-22
4. Raynaud FI, Orr RM, Goddard PM, et al. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice. J Pharmacol Exp Ther 1997 Apr; 281 (1): 420-7
5. Dean N, McKay R, Miraglia L, et al. Inhibition of growth and human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res 1996 Aug; 56 (15): 3499-507
6. Flores-Aguilar M, Besen G, Vuong C, et al. Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015. J Infect Dis 1997 Jun; 175 (6): 1308-16
7. Choi BM, Kwak HJ, Jun CD, et al. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides. Immunol Cell Biol 1996 Apr; 74 (2): 144-50
8. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996 Sep; 2 (9): 998-1004
9. Agrawal S, Zhang X, Lu X, et al. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Biochem Pharmacol 1995 Aug; 50 (4): 571-6
10. Stepkowski SM. Application of antisense oligonucleotides for organ transplantation. Transplant Proc 1998; 30: 2142-5
11. Kreig, AM. The CpG motif: implications for clinical immunology. BioDrugs 1998 Nov; 10 (5): 341-6
12. Spiegleberg HL, Tighe H, Roman M, et al. Inhibition of IgE formation and allergic inflammation by allergen gene immunization and by CpG motif immunostimulatory oligonucleotides. Allergy 1998; 53: 93-7
13. Metzger WJ, Nyce JW. Oligonucleotide therapy of allergic asthma. J Allergy Clin Immunol 1999 Aug; 104 (2): 260-6
14. Anonymous. Asthma - United States. 1982-1997 MMWR, Morbid Mortal Wkly Rep 1995; 43 (51-52): 952-5
15. Barnes PJ, Jonsson B, Klim JB, et al. The costs of asthma. Eur Respir J 1996; 9 (4): 636-42
16. Albrecht T, Schwab R, Peschel C, et al. Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells; uptake, biologic effects and modulation of gene expression. Ann Hematol 1996 Feb; 72 (2): 73-9
17. Ali S, Mustafa SJ, Metzger WJ. Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol. Agent Actions 1992; 37: 165-7
18. Minton NA, Henry JA. Treatment of theophylline overdose. Am J Emerg Med Oct 1996; 14 (6): 606-12
19. Ali S, Leonard SA, Kukoly C, et al. Pharmacokinetics of a respirable antisense oligonucleotide (Epi-2010) following aerosol delivery in rabbits [abstract]. Am J Respir Crit Care Med 1999; 159 Suppl.: A626
20. 1 receptor. J Pharmacol Exp Ther 1993; 268: 1328-34
21. Ali S, Mustafa SJ, Metzger WJ. Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in an allergic rabbit model. Am J Physiol 1994; 266: L271-7
22. Björck T, Gustafsson LE, Dhalen SE. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 1992; 145: 1087-91
23. Marone G. The relevance of adenosine receptor bearing cells in inflammatory disorders. In: Marone G, Lichtenstein L, Condorelli M, et al., editors. Human inflammatory disease. Philadelphia (PA): BC Decker, 1988: 239-54
24. 2h receptors evoke interleukin-8 secretion in human mast cells: an enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 1995; 96: 1979-86
25. Marquardt LM, Walker LL, Heinemann S. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 1994; 152: 4508-15
26. Joad JP. Characterization of the human peripheral lung adenosine receptor. Am J Respir Cell Mol Biol 1990; 2: 193-8
27. Joad JP, Kott KS. Effect of adenosine receptor ligands of cAMP in human airways and peripheral lung. Am J Respir Cell Mol Biol 1993; 9: 134-40
28. Hakonarson H, Shanbaky I, Guerra FM, et al. Modulation of adenosine-A1, Bradykinin-B1, and histamine-H1 receptor expression and function in atopic asthmatic sensitized airway smooth muscle [abstract], Am J Respir Crit Care Med 1998; 157: A662
29. Crimi N, Polosa R, Mistretta A. Purine derivatives in the study of allergic inflammation in respiratory diseases. Allergy 1997; 52 Suppl. 34: 48-54
30. Driver AG, Kukoly CA, Metzger WJ, et al. Bronchial challenges with adenosine causes the release of serum neutrophil chemotactic factor in asthma. Am Rev Respir Dis 1991 May; 143 (5): 1002-7
31. Driver AG, Kukoly CA, Ali S, et al. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993 Jul; 148 (1): 91-7
32. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 1996; 88 (9): 3569-74
33. 3 receptor expression and function in eosinophils. Am Respir Cell Mol Biol 1997; 16 (5): 531-7
34. Ali S, Mustafa SJ, Fisher RH, et al. Effects of theophylline and enprofylline on allergen-induced asthmatic responses in allergic rabbits [abstract]. Am Rev Respir Dis 1993; 147: A24
35. Ali S, Mustafa SJ, Knox C, et al. Effects of bectomethasone on allergen-induced airway obstruction, bronchial hyperresponsiveness and cell infiltration in allergic rabbits. J Allergy Clin Immunol 1994 Jan; 93 (Pt 2): 186
36. Mc Kenna M, Nyce JW, Welch C, et al. Duration of effect of a respirable antisense oligonucleotide (RASON) EPI-2010 for the adenosine A1 receptor [abstract]. J Allergy Clin Immunol 1998; 101 (2): S233
37. Nyce JW. Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases. Exp Opin Invest Drugs 1997; 6 (9): 1-7